Inventor · Wolfisheim, FR

Gilles Guichard

26Patents
5h-index
47Co-inventors
69Inventor score

Filing activity: Sep 13, 1996 → Jan 17, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US7741280B2 Multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments Emerging Cross-Sectional Technologies 13 Active
US7060845B2 Stabilized activated derivatives of carbamic acid, their process of preparation and their use for the preparation of ureas Chemistry; Metallurgy 8 Expired
US7186828B2 Cyclic urea compounds and preparation thereof Emerging Cross-Sectional Technologies 7 Expired
US7186739B2 Stabilized activated derivatives of carbamic acid, their process of preparation and their use for the preparation of ureas Chemistry; Metallurgy 7 Expired
US7691807B2 Hybrid oligomers, their preparation process and pharmaceutical compositions containing them Chemistry; Metallurgy 5 Expired
US6455244B1 Methods for the detection of antibodies associated with autoimmune disorders and infectious agents employing immunoretroid peptides derived from antigens associated with said disorders and agents Emerging Cross-Sectional Technologies 5 Expired
US8138145B2 Hybrid oligomers, their preparation process and pharmaceutical compositions containing them Chemistry; Metallurgy 4 Active
US7872098B1 Phosphorylated derivatives of a U1-70K peptide and their use in the treatment of autoimmune pathologies Human Necessities 2 Active
US8497349B2 Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation Human Necessities 2 Active
US7122193B1 Retro peptides, antibodies thereto and their uses for vaccination and in vitro diagnosis Emerging Cross-Sectional Technologies 1 Expired
US10398750B2 Peptide-oligourea chimeric compounds and methods of their use Human Necessities 1 Active
US9133240B2 Compounds binding to the bacterial beta ring Emerging Cross-Sectional Technologies 0 Active
US12098217B2 Fusion peptides as antimicrobial agents Chemistry; Metallurgy 0 Active
US9243030B2 Optically pure compounds for improved therapeutic efficiency Human Necessities 0 Active
US7691899B2 Urea oligomers, the preparation method thereof and pharmaceutical composition containing same Chemistry; Metallurgy 0 Expired
US8071640B2 Urea oligomers, their preparation process and pharmaceutical compositions containing them Chemistry; Metallurgy 0 Active
US10889627B2 Pro-drug peptide with improved pharmaceutical properties Human Necessities 0 Active
US7777030B2 Compositions and methods for the treatment and prevention of disease Emerging Cross-Sectional Technologies 0 Active
US8357654B2 Multimeric CD40 ligands, method for preparing same and use thereof for preparing drugs Human Necessities 0 Active
US11285219B2 Peptide-oligourea hybrid compounds Human Necessities 0 Active
US10414722B2 Bioinspired catalysis using oligourea helical foldamers Chemistry; Metallurgy 0 Active
US9040513B2 Process for preparing platinum-carbene complexes Chemistry; Metallurgy 0 Active
US9254309B2 Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation Human Necessities 0 Active
US8475800B2 Phosphorylated derivatives of a U1-70K peptide and their use in the treatment of autoimmune pathologies Human Necessities 0 Active
US10233213B2 Foldamer helix bundle-based molecular encapsulation Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.